Clinical trial

Study of the Efficacy of ESTRATEST® H.S. Tablets in Relieving Menopausal…

NCT00141570 · Solvay Pharmaceuticals, Industry · Completed

Key facts

NCT number NCT00141570
Title Study of the Efficacy of ESTRATEST® H.S. Tablets in Relieving Menopausal Symptoms in Estrogenized Postmenopausal Women
Official title A Multi-Center, Double-Blind Study to Determine the Efficacy of ESTRATEST® H.S. Tablets in Relieving Menopausal Symptoms in Estrogenized Postmenopausal Women
Lead sponsor Solvay Pharmaceuticals, Industry
Status Completed
Phase Phase 2
Study type Interventional
Conditions Menopause
Intervention type Drug
Interventions esterified estrogens 0.625 mg and methyltestosterone 1.25 mg
Enrollment 350
Start date Jun 1, 2004
Primary completion Jun 1, 2007
Completion Jun 1, 2007
First posted Sep 1, 2005
Last update posted Jan 16, 2015
Countries United States

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies